Attempt to disqualify Baker Botts denied

Spencer Parts

07 June 2019

A federal judge has denied Takeda Pharmaceuticals’ request that Baker Botts be disqualified from representing Zydus Pharmaceuticals in antitrust litigation against Takeda.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Spencer Parts

View full biography

Author

Tipline

Take two: The Tipline for 30 November 2023
If at first you don’t succeed, merge, merge again. The Obama Administration thwarted insurance mergers involving Cigna and Humana but it seems the companies want to pick another fight with the Department of Justice. The Wall Street Journal reported yesterday that the insurers are in talks to combine, in what would be the largest merger of the year, with both companies already trying to sell off competing assets.
Lights, in camera, action: The Tipline for 29 November 2023
Bayewatch: The Tipline for 28 November 2023